Craig Parker

Mr. Craig C.
Parker is a Venture Partner at The Column Group LLC, a President, Chief Executive Officer & Director at Surrozen Operating, Inc., a President, Chief Executive Officer & Director at Surrozen, Inc. and a Chairman-Leadership Council at University of Michigan.
He is on the Board of Directors at Surrozen Operating, Inc. and Surrozen, Inc. Mr. Parker was previously employed as an Independent Director by vTv Therapeutics, Inc., a Senior VP-Corporate Development by Jazz Pharmaceuticals Plc, an EVP-Corporate Development & Scientific Affairs by Geron Corp., a Senior VP-Strategy & Corporate Development by Human Genome Sciences, Inc., a Chief Executive Officer by Vega Therapeutics, Inc., a Senior Vice President & General Manager by Immunex Corp., a Managing Director by Lehman Brothers, Inc., and a Chief Financial Officer by Proteolix, Inc. He also served on the board at Gryphon Therapeutics, Inc. He received his undergraduate degree from The University of Chicago, an MBA from the University of Michigan, an MBA from Stephen M.
Ross School of Business and a doctorate degree from Georgetown University School of Medicine.